Connect with us

Technology

Axtria Showcases AI-Powered Innovations at PMSA 2024 Fall Symposium

Published

on

Axtria showcases its collaboration with leading pharma companies on AI-driven insights, field force optimization, and data strategies.

CHICAGO, Oct. 8, 2024 /PRNewswire/ — Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, shared its leadership in driving innovative solutions for life sciences companies at the PMSA 2024 Fall Symposium. The two-day summit, held in Chicago on October 3-4, 2024, brought together industry leaders, researchers, and academics to explore the transformative impact of AI in healthcare. Axtria earned several awards at the conference for thought leadership presentations, and once again participated as a gold sponsor, reiterating its commitment to exchanging knowledge to enhance the impact of AI in the pharmaceutical industry.

“At Axtria, we believe that AI is not just a tool, but a transformative force that can reshape the pharmaceutical landscape,” said Sudip Chakraborty, Principal and Head of AI/GenAI at Axtria. “Our participation in the PMSA 2024 Fall Symposium reflects our commitment to partnering with industry leaders to harness AI-driven insights and solutions that enhance decision-making, optimize field operations, and ultimately improve patient outcomes.”

Axtria’s experts, alongside client partners, led insightful presentations and discussions, showcasing advanced AI-driven solutions and strategies tailored for the pharmaceutical industry:

Axtria, alongside Gilead Sciences, presented a case study on Nuances of Leveraging Generative AI for Structured Data Processing and Insights. This highlighted the importance of empowering non-technical users to access insights via natural language generation-based applications. These GenAI-powered tools provide intuitive user interfaces with robust data access controls, enabling broader access to critical insights.

Axtria teamed up with Astellas Pharma to present a case study on AI-Enabled Action Alerts to Enhance Field Effectiveness. This collaboration demonstrated how AI-powered recommendations are transforming field operations by providing reps with actionable insights to optimize their engagements, increase prescription (Rx) uptake, and enhance overall brand performance. This presentation showed how Astellas and Axtria worked together to leverage data, convert it to useful rep suggestions, and ultimately improve brand performance through better field execution.

Together with Bayer, Axtria discussed Utilizing AI to Identify Unrealized Opportunities and Optimize End-to-End Field Force Operations. This session explored Bayer’s AI-driven transformation of field force operations across design, planning, execution, and talent management, showcasing the tangible business impact of AI.

Axtria led a session on Enabling EDA Automation for Commercial Analytics using LLM. This workshop demonstrated how generative AI can automate exploratory data analysis (EDA) processes, transforming raw data into actionable insights. Additionally, Axtria also conducted a focus session on Accelerating Pharma Business Analytics with AI-Ready Data Products Strategy. Axtria shared how AI-ready data products can streamline data management, unify fragmented data landscapes, and accelerate analytics while reducing operational costs.

About Axtria’s Products and Solutions
Axtria is proud to work with 16 of the top 20 life sciences companies, globally. From our roots as a trusted consultant to our status as one of the world’s leading providers of cloud-based pharmaceutical management software, Axtria has been powering the digital transformation of life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria InsightsMAx™ helps everyone from the C-suite to junior associates uncover trends to make better decisions. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration.

About Axtria
Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We’re proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.

Logo – https://mma.prnewswire.com/media/2256316/Axtria_transparent_bg_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/axtria-showcases-ai-powered-innovations-at–pmsa-2024-fall-symposium-302269330.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Innovation in Isolation: New Book Commissioned by MacPaw Explores Ukraine’s Historic Contributions to Tech, Supporting Critical Humanitarian Aid

Published

on

By

All proceeds will be donated to MacPaw Foundation, a non-profit organization established by MacPaw, to provide aid for civilians affected by russia’s invasion of Ukraine

BOSTON, Oct. 8, 2024 /PRNewswire/ — Innovation in Isolation: The Story of Ukrainian IT from the 1940s to the Present explores Ukraine’s pivotal role in the birth of computer science and its transformation from a former part of the Soviet Union to a thriving European innovation hub and is now available for preorder online. The book will be published on February 11, 2025 ahead of the third anniversary of russia’s unjust invasion of Ukraine. Commissioned by MacPaw – a global software company with deep Ukrainian roots –  published by IST Publishing, and distributed by Pathway Book Service in the U.S., all proceeds from Innovation in Isolation will support MacPaw Foundation’s humanitarian relief efforts in Ukraine. These funds will be directed to emergency wartime medical assistance in Ukraine’s most remote and inaccessible areas, a critical need in the face of russia’s ongoing aggression.

From the development of the first computer in Ukraine in the 1940s to its emergence as a global tech hub in the 21st century, Innovation in Isolation chronicles Ukraine’s pivotal role in the birth of computer science. Featuring exclusive interviews spanning generations with compelling illustrations and original photographs never before seen in the West, the book brings to life the untold stories of overlooked geniuses including Sergey Lebedev (1902–1974) and Victor Glushkov (1923-1982).

“We created Innovation in Isolation to shed light on the profound history of Ukraine’s IT industry and to show the world how Ukraine has produced so many talented engineers and IT specialists,” said Oleksandr Kosovan, Founder and CEO of MacPaw. “For decades, Soviet authorities and Moscow elites distorted our history, often claiming our inventions and the names of our inventors as their own. This book will fix that narrative, celebrating the true pioneers who helped Ukraine become a modern tech hub. I hope that readers find this exploration of Ukrainian history both enlightening and inspiring, recognizing the resilience and brilliance of these remarkable Ukrainian minds.”

Innovation in Isolation celebrates Ukraine’s achievements and offers valuable insights into the lessons learned under the oppression and propaganda of the former Soviet Union. This book offers readers a powerful message for today: Ukraine’s innovative spirit continues to thrive despite russian aggression. By examining Ukraine’s resilience and innovation in the face of adversity, readers will gain a deeper appreciation of Ukraine’s tech landscape and the indomitable spirit of its people.

For more information about Innovation in Isolation, visit https://www.innovation-in-isolation.com.

About MacPaw

MacPaw develops and distributes innovative software for macOS and iOS that simplifies the lives of Mac users. Renowned for its meticulously crafted products, such as CleanMyMac X, CleanMy®Phone, Setapp, and ClearVPN, and known for its Moonlock cybersecurity division, MacPaw is dedicated to enhancing and securing the Mac user experience. Founded in Kyiv, Ukraine, with a subsidiary office in Boston, MacPaw serves over 30 million users worldwide. With one in every five Mac users having at least one MacPaw app, the company is a trusted leader in the Mac software ecosystem.

To learn more about the MacPaw Foundation, visit https://macpaw.foundation.

For review copies of the book and interview requests, please contact:
Julia Drake | Wildbound PR | julia@wildboundpr.com | (310) 359-6487

Photo – https://mma.prnewswire.com/media/2521778/Innovation_in_Isolation.jpg

View original content:https://www.prnewswire.co.uk/news-releases/innovation-in-isolation-new-book-commissioned-by-macpaw-explores-ukraines-historic-contributions-to-tech-supporting-critical-humanitarian-aid-302265964.html

Continue Reading

Technology

Purpose-built, Flexible Life Science Facilities are the Leading Design and Construction Trend

Published

on

By

Tenant needs shaping move toward flexible spaces that are ready for move-in

COLUMBIA, Md., Oct. 8, 2024 /PRNewswire/ — Demand toward life sciences manufacturing space when compared to innovation and R&D is driving the shift in tenant needs in the market, leading to changes in how architects and contractors’ partner with clients, said Abhishek Dhawan, DPR Construction’s Mid-Atlantic life sciences leader at Bisnow’s Life Sciences Summit.

“The advancement in science and technology has enhanced the need for life science buildings to accommodate continual adjustments in space and use by various tenants and companies,” Dhawan said. “Purpose-built, flexible facilities are the leading design and construction trend in the market.”

With a robust level of drug clinical trials driven by major pharmaceutical firms, the need for move-in-ready space and cGMP manufacturing is very important. However, with tight budgets and consistent advancements in the science and technology, architects and contractors are helping firms maintain a balance between these conflicting concerns.

Dhawan also noted that:

Facilities are being built to accommodate collaboration spaces, vibration sensitive equipment, efficient airflows and exhaust, mechanical/electrical/plumbing for multi-purpose facility use.Shared lab amenities that bring more flexibility in buildings include low temperate product storage, central glass wash/autoclave, data center, cleanroom and fabrication shops.Living plant walls, noise control, and increased access to daylight and fresh air make these buildings healthier for everyone who works in them. Moreover, incorporating features that encourage wellness, such as open and accessible stairways, dedicated fitness spaces and showers, and even outdoor dining, walking paths and bike storage rooms.

About DPR Construction

DPR Construction is a forward-thinking, self-performing general contractor and construction manager specializing in technically complex and sustainable projects for the advanced technology, life sciences, healthcare, higher education and commercial markets. DPR’s portfolio of work ranges from large-scale new construction to small tenant improvements and special projects. Founded in 1990, DPR is a great story of entrepreneurial success as a private, employee-owned company that has grown to a multi-billion-dollar organization with offices around the world. Strategically focused on delivering more predictable outcomes through applications of virtual design & construction, prefabrication, its team of self-perform craft, and leveraging data to learn and improve from DPR consistently ranks among the top building contractors and employs approximately 11,000 professionals across its family of companies. For more information, visit http://www.dpr.com.

For more information, please contact:

Lisa Ruano
DPR Construction
Tel: 908-451-9622
Email: lisaru@dpr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/purpose-built-flexible-life-science-facilities-are-the-leading-design-and-construction-trend-302268886.html

SOURCE DPR Construction

Continue Reading

Technology

Earnest Analytics launches US consumer spending index based on credit card spending

Published

on

By

NEW YORK CITY, N.Y., Oct. 8, 2024 /PRNewswire/ — Earnest Analytics, the leading data analytics firm for investors, companies, and consulting firms, has released a new Earnest Analytics Spend Index (EASI), powered by the Vela Gamma transaction dataset.

Earnest Analytics has released a new Earnest Analytics Spend Index, powered by the Vela Gamma transaction dataset.

The new Earnest Analytics Spend Index is an alternative data-driven measure of consumer activity that tracks spending across 89 merchant category codes (MCC), encompassing thousands of US merchants. The near real-time data is derived from the credit and debit card activity of millions of de-identified US consumers.

“The macroeconomic environment is more topical than ever as interest rates change and consumer sentiment cools,” said Michael Maloof, Vice President and Head of Marketing at Earnest Analytics. “The EASI gives investors and corporate managers a real-time look into shopper behavior, by location and income, weeks before traditional sources. It is an unprecedented view under the hood of the consumer economy.”

Earnest Analytics customers will also be able to drill down into the sectors driving changes in the EASI, as well as geographies, demographics, and credit vs debit sources. 

The new EASI is highly predictive of the US Census Bureau’s Monthly Retail Trade Survey. 

The new EASI is currently available via Earnest Analytics’s proprietary web-based analytics platform Earnest Dash (see September report here) as well as BigQuery, S3, and Snowflake.

For more information on Earnest Analytics or to schedule a demo, visit:
https://www.earnestanalytics.com/schedule-a-demo-form/

About Earnest Analytics
Founded in 2012, Earnest Analytics measures the consumer and healthcare economies with real-time data, providing actionable insights for institutional investors, companies, consultants, and government agencies. Our structured datasets provide clear, correlated signals, with tools for deep fundamental analytics on Consumer Spend, Retail Pricing, CPG, and Healthcare Claims. Earnest Analytics enables companies to deeply understand consumer habits and national health trends. For more information visit www.earnestanalytics.com.

For Press Inquiries Please Contact
Deanna Kim, Senior Marketing & Media Relations Associate
dkim@earnestanalytics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/earnest-analytics-launches-us-consumer-spending-index-based-on-credit-card-spending-302270298.html

SOURCE Earnest Analytics

Continue Reading

Trending